ArticleFrontiers in endocrinology2025

Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells.

Donatella Treppiedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.